Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.460
+0.080 (3.36%)
At close: Jun 26, 2026, 4:00 PM EDT
2.550
+0.090 (3.66%)
After-hours: Jun 26, 2026, 5:57 PM EDT
Lipocine Employees
Lipocine had 14 employees as of December 31, 2025. The number of employees decreased by 2 or -12.50% compared to the previous year.
Employees
14
Change (1Y)
-2
Growth (1Y)
-12.50%
Revenue / Employee
$143,015
Profits / Employee
-$816,752
Market Cap
20.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Palatin Technologies | 29 |
| NewcelX | 12 |
| Tvardi Therapeutics | 12 |
| Cellectar Biosciences | 11 |
| VYNE Therapeutics | 10 |
| Allarity Therapeutics | 8 |
| AEON Biopharma | 8 |
LPCN News
- 15 days ago - Lipocine Transcript: KOL event - Transcripts
- 15 days ago - Lipocine Slides: KOL event - Filings
- 23 days ago - Lipocine Inc. to Host Virtual KOL Event Highlighting Unmet Needs in Postpartum Depression and the Clinical Profile of LPCN 1154 - PRNewsWire
- 5 weeks ago - Lipocine Transcript: A.G.P.'s Annual Virtual Healthcare Conference - Transcripts
- 5 weeks ago - Lipocine Announces LPCN 1154 Phase 3 Data Accepted for Oral Presentation at 2026 ASCP Annual Meeting - PRNewsWire
- 5 weeks ago - Anaveon Strengthens Leadership Team with Appointments of Eric Zanelli as Chief Scientific Officer and Jill Jene as Chief Business Officer - GlobeNewsWire
- 5 weeks ago - Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase - PRNewsWire
- 7 weeks ago - Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026 - PRNewsWire